Bookmark and Share

Meredith  Bond
 

Meredith Bond Ph.D.

Academic Title: Professor
Primary Appointment: Physiology
Secondary Appointments: Medicine
Administrative Title: Chair
mbond@som.umaryland.edu
Location: 655 West Baltimore St. BRB 5-007
Phone: 410-706-1922
Fax: 410-706-8341
Lab: 410-706-2315

Personal History

I grew up in Sydney, Australia. Obtained a B.A. from Macquarie University in Sydney in 1976. Worked for two years as a technician for Britton Chance at the University of Pennsylvania and then obtained a PhD in Physiology from the Pennsylvania Muscle Institute and Dept of Physiology, University of Pennsylvania. I was then a post-doctoral fellow and Research Associate with Andrew and Avril Somlyo at the University of Pennsylvania. I moved to Cleveland in 1986 to take up a position as Staff in the Department of Molecular Cardiology in the Research Institute of the Cleveland Clinic Foundation. I also have an adjunct faculty appointment in the Department of Physiology and Biophysics, Case Western Reserve University. My research has been continually funded by NIH and is currently funded by 2 NIH grants. Over the years, I have been fortunate to have four graduate students obtain their PhD in my lab, over 15 post-doctoral fellows train with me and over 25 undergraduate students spend summers in my lab. I moved to Baltimore in September 2003 to become Professor and Chair of the Department of Physiology at the University of Maryland School of Medicine.

Research Interests

Area of general research interest:

β-adrenergic pathways in hypertrophied and failing hearts, cardiac function, role of protein kinases, regulation of phosphorylation of myofibrillar proteins in the heart; role of A-kinase anchoring proteins (AKAPs) in protein kinase A (PKA) targeting; genomic and proteomic analysis of human heart failure.

Current program:

β-adrenergic pathways and troponin I phosphorylation in hypertrophied and failing hearts; gene expression profiling in human heart failure.

Regulation of cAMP dependent protein kinase (PKA) is determined in part by sub-cellular targeting of PKA by A-kinase anchoring proteins (AKAPs). Anchoring of PKA by AKAPs increases the local concentration of PKA, thus directing the kinase to specific substrates. My lab investigates downstream regulation of the β-adrenergic signaling pathway by AKAP targeted PKA. Our work in animal models of cardiac hypertrophy and failure and in failing human hearts has shown that this downstream regulation of the β-adrenergic signal transduction pathway is impaired in diseased hearts, resulting in altered substrate phosphorylation.

We are currently investigating the functional role of AKAPs in the heart. We have disrupted PKA interaction with endogenous AKAPs in cardiac myocytes by introducing an inhibitory peptide, Ht31, via adenoviral gene transfer. Our results provide the first evidence of the importance of PKA targeting by AKAPs in the regulation of PKA substrate phosphorylation and of cardiac contractility., We are currently introducing Ht31 peptide by adenoviral gene transfer into rat hearts in vivo and determining the effect on cardiac contractility by echocardiography. We have also identified a novel AKAP in the heart - the intermediate filament protein, synemin. We hypothesize that synemin targets PKA to the cytoskeleton, regulating phosphorylation of cytoskeletal and sarcomeric substrates.

We are also performing gene expression profiling in failing and non-failing human hearts by high density oligonucleotide arrays. These measurements allow identification of clusters of genes with altered expression in human heart failure and have revealed distinct gene fingerprints of human heart failure of different etiologies.

Lab Techniques and Equipment

  • Isolation of rat cardiac myocytes and measurement of cytosolic Ca2+ and cell shortening
  • Adenoviral gene transfer in isolated myocytes and rat heart in vivo
  • Non-invasive assessment of cardiac contractility in rodents by echocardiography
  • Fluorescent resonance energy transfer of GFP-tagged proteins and peptides in cells
  • Oligonucleotide microarray analysis of gene expression in the heart
  • Measurement of substrate phosphorylation by back-phosphorylation and by mass-spectrometry
  • Expression of wild type and mutant AKAPs and PKA in CHO and HEK cells
  • Confocal microscopy and immunofluorescent microscopy
  • Immunoprecipitation

Laboratory Personnel:

Bradley McConnell, PhD, Assistant Professor
Brad's B.S. degree in Biology was from The Pennsylvania State University, and his Ph.D. in Physiology and Biophysics was from Case Western Reserve University. Brad worked as a graduate student with Dr. Meredith Bond at The Cleveland Clinic Foundation where he worked on the regulation of beta-adrenergic pathway in hypertrophied and failing hearts. He worked as a postdoctoral fellow at Harvard Medical School in the laboratory of Drs. Christine and Jonathan Seidman, studying the physiological processes of human genetic pathologies that alter cardiac structure and function. At the University of Maryland, Brad's research interests are focused on investigating strategies to improve cardiac function during heart failure using molecular, biochemical, cellular and physiological technologies.

 

Linda Lund, PhD, Research Associate
Linda's undergraduate degree was in Biology/Chemistry from Portland State University, Portland, Oregon. She received a Ph.D. from Oregon Health Sciences University, Dept. of Biochemistry and Molecular Biology (’92). Her post-graduate studies were done at Case Western Reserve University, Dept. of Neuroscience in Cleveland, Ohio where her work focused on CaM Kinase II, regulation of cytoskeletal polymerization, and the intracellular transport of vesicle-associated and soluble proteins using rat peripheral nerves. Linda's current work in the Bond lab is related to the intermediate filament protein, synemin, which is found at adhesion sites on the sarcolemma of cardiac myocytes, and is also perinuclear and found at Z-lines. Synemin localizes PKA near substrates and is the first intermediate filament protein identified as an AKAP. Current studies focus on understanding the role of PKA localized by synemin on the formation and stabilization of the adhesion sites that form between heart cells. 

 

Sabrina Manni, PhD, Postdoctoral Fellow
Sabrina obtained a degree in Biological Science at the University of Padova, Italy, in 2000, as an undergraduate student in the Department of Biology in the lab of Elisabetta Bergantino. She was a graduate student in the lab of Dr. Ernesto Carafoli in the Department of Biological Chemistry, University of Padova, Italy, where she obtained a PhD in Biochemistry and Biophysics in 2004. The aim of Sabrina's PhD study was to evaluate the specific abilities of the calcium transporter to control calcium signals in different organelles of the cells in health and disease using aequorin probes. Following Sabrina's graduate studies, she joined the laboratory of Meredith Bond in the Department of Physiology, University of Maryland, Baltimore as a post-doctoral fellow.Sabrina tests the hypothesis that modulation of PKA: AKAP interaction by changes in the phosphorylation state of RII alters the cardiac contractile response to β-adrenergic stimulation. In particular she is investigates the effect of RII phosphorylation on RII: AKAP interaction in neonatal cardiomyocytes and in rat hearts in vivo. Adenoviral gene transfer of RII mutants (mutation in Ser 96; the RII phosphorylation site) are used to effect changes in RII:AKAP binding.

 

Jaclyn Kerr, Graduate Student
A native of Michigan, Jaclyn earned her undergraduate degree in Microbiology from the University of Georgia, where she was also involved in research on maternal effects on evolution in Drosophila in Daniel Promislow's laboratory. After gaining her Bachelors of Science, Jaclyn returned to Ann Arbor, MI to work as a research assistant at Pfizer for two years under Stephen Rapundalo. Following that, Jaclyn joined the PhD program in Physiology at the University of Maryland in 2003, and is currently funded by the Cardiovascular Training Grant at UMB. In Dr. Bond's lab, Jaclyn is working on identifying the proteins involved in PKA signalling via the intermediate filament protein, synemin, and its role in the development of heart failure.


Publications

1.       Tan, F.L., Moravec, C.S., Li, J., Apperson-Hansen, C., McCarthy, P.M., Young, J.B. and Bond, M. (2002) Gene expression fingerprint as a predictor of human heart failure and its etiology. Proc Natl Acad Sci USA 99: 11387-11392.

2.       Ruse, C.I., Willard, B., Jin, J.P., Haas, T., Kinter, M. and Bond, M. (2002) Kinetics and stoichiometry of protein phosphorylation at the amino acid level. Anal Chem, 74: 1658-1664.

3.       Ruehr, M.R., Russell, M.A., Ferguson, D., Scott, J.D., Bhat, M., Ma, J., Damron, D.S. and Bond, M. (2003) Targeting of protein kinase A by muscle A kinase-anchoring protein (mAKAP) regulates phosphorylation and function of the skeletal muscle ryanodine receptor. J Biol Chem, 278: 24831-24836.

4.       Masri, S.C., Yamani, M.H., Russell, M.A., Ratliff, N.B., Yang, J., Almasan, A., Apperson-Hansen, C., Li, J., Starling, R.C., McCarthy, P., Young, J.B. and Bond, M. (2003) Sustained apoptosis in human cardiac allografts despite histologic resolution of rejection. Transplantation, 76: 859–864.

5.       Ruse, C.I., Kinter, M. and Bond, M. (2004) Integrated analysis of the human cardiac transcriptome, proteome and phosphoproteome. Proteomics, 4: 1505-1516.

6.       Ruehr, M.L., Russell, M.R. and Bond, M. (2004) A-Kinase Anchoring Protein targeting of Protein Kinase A in the heart. J Mol Cell Cardiol, 37(3): 653-665.

7.       Barbato, J.C., Huang, Q-Q., Hossain, M.M., Bond, M. and Jin, J-P. (2005) Proteolytic N-Terminal Truncation of Cardiac Troponin I Enhances Ventricular Diastolic Function. J. Biol. Chem., 280: 6602 – 6609.

8.       Riddle, E., Schwartzman, R., Bond, M. and Insel, P. (2005) Multi-tasking RGS Proteins in the Heart: The next Therapeutic Target? Circ Res., 96: 401-411.

9.       Russell, M., Lund, L.M., Haber, R., McKeegan, K., Cianciola, N., Mizuno, Y., Bond, M. (2006) The Intermediate Filament Protein Synemin is an A-kinase Anchoring Protein. Arch Biochem Biophys, 456(2): 204-15.

10.   Barrows, B.R., Azimzadeh, A.A., Zhou, H., Vives-Rodriguez, G., McCulle, S.L., Stark, W.N., Ambulos, N., Jing, Y., Pierson, R.N. III, Johnson, F.L., Balke, C.W., Gottlieb, S.S., and Bond, M. (2007) Robust gene expression analysis using amplified RNA from biopsy-sized human heart tissue. J Mol Cell Cardiol, 42(1): 260-4.

11.   Mauban, JH, O’Donnell, M, Warrier, S, Manni, S, and Bond, M. AKAP-scaffolding proteins and regulation of cardiac physiology. Physiology (Bethesda). 2009 Apr;24:78-87. PMID: 19364910 [PubMed - in process]

12.   Manni S, Mauban JH, Ward CW, Bond M. Phosphorylation of the PKA regulatory subunit modulates PKA-AKAP interaction, substrate phosphorylation and calcium signaling in cardiac cells. J Biol Chem 283(35): 24145-24154, 2008.  PMID: 18550536

13.   McConnell BK, Popovic Z, Mal N, Lee K, Bautista J, Forudi F, Schwartzman R, Jin J.-P., Penn M, Bond M. Disruption of PKA/A-kinase Anchoring Protein Interaction: Effects on Cardiac Contractility, PKA Phosphorylation and Troponin I Proteolysis in hearts in vivo. J Biol Chem 284(3):1583-92, 2009.  PMID: 18945669.


Faculty members: Click here to update your contact information and create a profile.